Susquehanna International Group’s Immunocore IMCR Stock Holding History

Susquehanna International Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$260K	Sell	8,622 -26,566	-75%	-$859K	﹤0.01%	11178
2025 Q4	$1.22M	Buy	35,188 +24,995	+245%	+$882K	﹤0.01%	6727
2025 Q3	$370K	Buy	10,193 +1,299	+15%	+$44.1K	﹤0.01%	9638
2025 Q2	$279K	Buy	+8,894	New	+$276K	﹤0.01%	10511
2024 Q4	–	Sell	-112,199	Closed	-$3.55M	–	12670
2024 Q3	$3.49M	Buy	+112,199	New	+$4.08M	﹤0.01%	4266
2023 Q4	–	Sell	-4,386	Closed	-$228K	–	12796
2023 Q3	$228K	Buy	+4,386	New	+$260K	﹤0.01%	9944
2023 Q2	–	Sell	-19,727	Closed	-$1.13M	–	12572
2023 Q1	$975K	Sell	19,727 -1,608	-8%	-$90.4K	﹤0.01%	6883
2022 Q4	$1.22M	Sell	21,335 -21,243	-50%	-$1.2M	﹤0.01%	5761
2022 Q3	$2M	Sell	42,578 -14,831	-26%	-$707K	﹤0.01%	4932
2022 Q2	$2.14M	Buy	+57,409	New	+$1.86M	﹤0.01%	4769

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Susquehanna International Group's IMCR Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunocore (IMCR) stake by 75% in Q1 2026, selling an estimated $859K and leaving 8,622 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #11178.

Susquehanna International Group first reported a position in IMCR in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.49M in Q3 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Susquehanna International Group held 8,622 shares of Immunocore worth $260K as of Q1 2026.
Susquehanna International Group sold 26,566 Immunocore shares in Q1 2026, an estimated $859K.
Immunocore made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11178 holding.
Susquehanna International Group first reported a position in Immunocore in Q2 2022 and has held it in 10 quarters since.
Susquehanna International Group's Immunocore position peaked at $3.49M in Q3 2024.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.